{
    "title": "Protalix shares jump on report of possible Ebola drug technology",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-2746733/Protalix-shares-jump-report-possible-Ebola-drug-technology.html",
    "date": "2014-09-07",
    "keywords": [
        "drug",
        "technology",
        "zmapp",
        "plant",
        "ebola",
        "protalix",
        "report",
        "company",
        "tobacco",
        "percent",
        "antibody",
        "gmt",
        "september",
        "rabinovitch",
        "world",
        "stock",
        "virus",
        "outbreak",
        "email",
        "scheerjerusalem",
        "biotech",
        "sunday",
        "news",
        "treatment",
        "television",
        "saturday",
        "facility",
        "israel",
        "medicine",
        "plantsprotalix",
        "tel",
        "aviv",
        "afternoon",
        "companys",
        "chief",
        "executive",
        "collaboration",
        "manufacturer",
        "week",
        "start",
        "inc",
        "diego",
        "attention",
        "aid",
        "liberia",
        "doctor",
        "disease",
        "month",
        "trial",
        "group",
        "lab",
        "zmappin",
        "channel",
        "scientist",
        "production",
        "capacity",
        "timeprotalix",
        "ceo",
        "david",
        "aviezer",
        "protalixs",
        "gaucher",
        "diseasehe",
        "technique",
        "diseasesaviezer",
        "cellsin",
        "theory",
        "cell",
        "system",
        "dna",
        "sequence",
        "asset",
        "protein",
        "health",
        "organization",
        "west",
        "africa",
        "guinea",
        "march",
        "half",
        "contract",
        "scheer",
        "editing",
        "rosalind",
        "russell"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}